| PERIOD ENDING | 28-Feb-09 | 29-Nov-08 | 30-Aug-08 | 31-May-08 | | Total Revenue | 2,219 | 6,355 | 8,399 | 11,996 | | Cost of Revenue | 2,893 | 5,296 | 7,108 | 9,194 | | | Gross Profit | (674) | 1,059 | 1,291 | 2,802 | | | Operating Expenses | | Research Development | 1,675 | 1,734 | 2,036 | 2,288 | | Selling General and Administrative | 2,385 | 2,915 | 2,819 | 3,764 | | Non Recurring | 70 | 266 | 254 | 1,331 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,804) | (3,856) | (3,818) | (4,581) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (167) | (214) | (83) | (267) | | Earnings Before Interest And Taxes | (4,971) | (4,070) | (3,901) | (4,848) | | Interest Expense | 596 | 592 | 592 | 603 | | Income Before Tax | (5,567) | (4,662) | (4,493) | (5,451) | | Income Tax Expense | (1,020) | 10 | 15 | 103 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,547) | (4,672) | (4,508) | (5,554) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,547) | (4,672) | (4,508) | (5,554) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,547) | ($4,672) | ($4,508) | ($5,554) |
|
0.51% Nasdaq 
Income Statement
